HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

P-glycoprotein functions as an immunomodulator in healthy human primary nasal epithelial cells.

AbstractBACKGROUND:
P-glycoprotein (P-gp) is an adenosine triphosphate (ATP)-dependent efflux pump that confers chemotherapeutic resistance in cancer cells. Recent studies suggest that P-gp may also function as an immunomodulator through regulation of cytokine transport. Sinonasal epithelial cells have been recognized as drivers of local innate and adaptive immunity and are known to overexpress P-gp in the setting of inflammation. The objective of this study is to therefore determine whether P-gp participates in the regulation of cytokine secretion in sinonasal epithelial cells.
METHODS:
Primary nasal epithelial cell cultures (PNECCs) were cultivated from 5 healthy patients. Membranous P-gp was quantified through quantitative fluorescent immunohistochemistry (Q-FIHC) and confirmed by enzyme-linked immunosorbent assay (ELISA). Sensitivity to inhibition was determined using a rhodamine 123 accumulation assay. Baseline and lipopolysaccharide (LPS)-stimulated cytokine secretion of interleukin 6 (IL-6), IL-8, granulocyte macrophage colony stimulating factor (GM-CSF), and thymic stromal lymphopoietin (TSLP) were quantified by ELISA and compared to LPS stimulated secretion in the setting of P-gp-specific inhibition. Differences in P-gp expression and cytokine secretion were compared using 2-tailed Student t tests with post hoc testing using the Bonferroni procedure.
RESULTS:
Membranous P-gp is detectable in PNECCs and upregulated following LPS exposure. P-gp is sensitive to inhibition by both PSC 833 and verapamil in a dose-dependent fashion. LPS stimulated secretion of normalized IL-6 (mean, 95% confidence interval [CI]) (79.67, 42.26-117.07), GM-CSF (39.92, 7.90-71.94), and TSLP (6.65, 5.35-7.96) was significantly reduced following P-gp inhibition (37.60, 11.54-63.65, p = 0.023; 7.64, 2.25-13.03, p = 0.044; and 5.13, 4.44-5.82, p = 0.038; respectively).
CONCLUSION:
P-gp is functionally active in PNECCs. P-gp participates in modulation of epithelial secretion of LPS stimulated IL-6, GM-CSF, and TSLP.
AuthorsBenjamin S Bleier, Angela L Nocera, Hufsa Iqbal, John D Hoang, Rachel E Feldman, Xue Han
JournalInternational forum of allergy & rhinology (Int Forum Allergy Rhinol) Vol. 3 Issue 6 Pg. 433-8 (Jun 2013) ISSN: 2042-6984 [Electronic] United States
PMID23520057 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2013 ARS-AAOA, LLC.
Chemical References
  • ATP Binding Cassette Transporter, Subfamily B, Member 1
  • Cytokines
  • Fluorescent Dyes
  • Interleukin-6
  • Interleukin-8
  • Lipopolysaccharides
  • Rhodamine 123
  • Granulocyte-Macrophage Colony-Stimulating Factor
  • Verapamil
  • Thymic Stromal Lymphopoietin
Topics
  • ATP Binding Cassette Transporter, Subfamily B, Member 1 (antagonists & inhibitors, metabolism)
  • Cytokines (metabolism)
  • Enzyme-Linked Immunosorbent Assay
  • Epithelial Cells (metabolism)
  • Fluorescent Dyes
  • Granulocyte-Macrophage Colony-Stimulating Factor (metabolism)
  • Humans
  • Interleukin-6 (metabolism)
  • Interleukin-8 (metabolism)
  • Lipopolysaccharides (pharmacology)
  • Nasal Cavity (metabolism)
  • Rhodamine 123
  • Verapamil (pharmacology)
  • Thymic Stromal Lymphopoietin

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: